82 related articles for article (PubMed ID: 2643078)
1. [The lupus anticoagulant and its clinical significance].
Udvardy M
Orv Hetil; 1989 Jan; 130(1):9-12. PubMed ID: 2643078
[No Abstract] [Full Text] [Related]
2. Chorea, systemic lupus erythematosus, circulating lupus anticoagulant.
Hatron PY; Bouchez B; Wattel A; Arnott G; Devulder B
J Rheumatol; 1986 Oct; 13(5):991-3. PubMed ID: 3102729
[No Abstract] [Full Text] [Related]
3. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
Moore GW; Rangarajan S; Savidge GF
Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
[TBL] [Abstract][Full Text] [Related]
4. The association of antibodies to cardiolipin, beta 2-glycoprotein I, prothrombin, and oxidized low-density lipoprotein with thrombosis in 292 patients with familial and sporadic systemic lupus erythematosus.
Koskenmies S; Vaarala O; Widen E; Kere J; Palosuo T; Julkunen H
Scand J Rheumatol; 2004; 33(4):246-52. PubMed ID: 15370721
[TBL] [Abstract][Full Text] [Related]
5. [Antiphospholipid antibodies: clinical significance and biological diagnosis].
Arnoux D; Boutière B; Sanmarco M
Ann Biol Clin (Paris); 2000; 58(5):557-74. PubMed ID: 11022099
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity and diversity of IgM and IgG lupus anticoagulants in an individual with systemic lupus erythematosus.
Nakamura N; Azuma C; Akamizu T; Sugawa H; Matsuda F; Mitsuda N; Honjo T; Mori T; Yamaji K
Biochem Biophys Res Commun; 1994 Sep; 203(3):1789-94. PubMed ID: 7945329
[TBL] [Abstract][Full Text] [Related]
7. Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus.
Senécal JL; Rauch J; Grodzicky T; Raynauld JP; Uthman I; Nava A; Guimond M; Raymond Y
Arthritis Rheum; 1999 Jul; 42(7):1347-53. PubMed ID: 10403261
[TBL] [Abstract][Full Text] [Related]
8. Phospholipid specificity of autoimmune and drug induced lupus anticoagulants; association of phosphatidylethanolamine reactivity with thrombosis in autoimmune disease.
Drouvalakis KA; Buchanan RR
J Rheumatol; 1998 Feb; 25(2):290-5. PubMed ID: 9489821
[TBL] [Abstract][Full Text] [Related]
9. Thromboelastography assessment of coagulation status in parturients with lupus anticoagulant receiving heparin therapy.
Harnett M; Kodali BS
Int J Obstet Anesth; 2006 Apr; 15(2):177-8. PubMed ID: 16488131
[No Abstract] [Full Text] [Related]
10. The dilute phospholipid APTT: a sensitive assay for verification of lupus anticoagulants.
Alving BM; Baldwin PE; Richards RL; Jackson BJ
Thromb Haemost; 1985 Oct; 54(3):709-12. PubMed ID: 3937268
[TBL] [Abstract][Full Text] [Related]
11. [Circulating anticoagulants in disseminated lupus erythematosus. Apropos of 3 cases].
Krulik M; Tobelem G; Audebert AA; Mougeot-Martin M; Debray J
Ann Med Interne (Paris); 1977 Jan; 128(1):57-62. PubMed ID: 855970
[No Abstract] [Full Text] [Related]
12. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
Swadzba J; De Clerck LS; Stevens WJ; Bridts CH; van Cotthem KA; Musial J; Jankowski M; Szczeklik A
J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
[TBL] [Abstract][Full Text] [Related]
13. [Antiphospholipid antibodies, thrombosis and lupus disease. Value of the assay of anticardiolipin antibodies by the ELISA technic].
Meyer O; Cyna L; Borda-Iriarte O; Jungers P; Piette JC; Dautzenberg MD; Dupuy E; Ryckewaert A
Rev Rhum Mal Osteoartic; 1985 May; 52(5):297-305. PubMed ID: 3874416
[TBL] [Abstract][Full Text] [Related]
14. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
Viveros ME; Cabiedes J; Reyes E; Cabral AR
Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
[TBL] [Abstract][Full Text] [Related]
15. Antiphospholipid antibodies: a disease marker in 25 patients with antinuclear antibody negative systemic lupus erythematosus (SLE). Comparison with a group of 91 patients with antinuclear antibody positive SLE.
Meyer O; Piette JC; Bourgeois P; Fallas P; Bletry O; Jungers P; Kahn MF; Godeau P; Ryckewaert A
J Rheumatol; 1987 Jun; 14(3):502-6. PubMed ID: 3114485
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of antibodies to histones in systemic lupus erythematosus.
Kohda S; Kanayama Y; Okamura M; Amatsu K; Negoro N; Takeda T; Inoue T
J Rheumatol; 1989 Jan; 16(1):24-8. PubMed ID: 2785597
[TBL] [Abstract][Full Text] [Related]
17. Studies on a circulating anticoagulant in procainamide-induced lupus erythematosus.
Edwards RL; Rick ME; Wakem CJ
Arch Intern Med; 1981 Nov; 141(12):1688-90. PubMed ID: 6171218
[TBL] [Abstract][Full Text] [Related]
18. [Lupus anticoagulant screening: comparison of 5 tests (author's transl)].
Follea G; Ffrench P; Trzeciak MC; Dechavanne M
Nouv Rev Fr Hematol (1978); 1981; 23(4):203-7. PubMed ID: 7312614
[TBL] [Abstract][Full Text] [Related]
19. IgG binding to endothelial cells in systemic lupus erythematosus.
Le Roux G; Wautier MP; Guillevin L; Wautier JL
Thromb Haemost; 1986 Oct; 56(2):144-6. PubMed ID: 2949388
[TBL] [Abstract][Full Text] [Related]
20. Enzyme-linked immunosorbent assay (ELISA) for detection of antibodies against glycosphingolipids and its application to patients with systemic lupus erythematosus.
Sanai Y; Ogawa J; Nagai Y
Jpn J Exp Med; 1981 Oct; 51(5):309-16. PubMed ID: 7321255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
